NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 74 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $10,605,000 | -2.9% | 364,800 | +1.2% | 0.23% | -0.4% |
Q4 2020 | $10,921,000 | +90.4% | 360,500 | +0.0% | 0.23% | +58.9% |
Q3 2020 | $5,735,000 | -18.7% | 360,454 | +0.9% | 0.15% | -24.7% |
Q2 2020 | $7,055,000 | +63.0% | 357,409 | +1.8% | 0.19% | +8.4% |
Q1 2020 | $4,329,000 | -33.3% | 351,100 | 0.0% | 0.18% | -12.7% |
Q4 2019 | $6,492,000 | +33.5% | 351,100 | 0.0% | 0.20% | +5.7% |
Q3 2019 | $4,863,000 | -5.4% | 351,100 | 0.0% | 0.19% | +4.3% |
Q2 2019 | $5,140,000 | – | 351,100 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 18,136,735 | $232,513,000 | 49.48% |
Ponoi II Management, LLC | 1,298,908 | $16,652,000 | 45.25% |
Ponoi Management, LLC | 1,298,908 | $16,652,000 | 26.29% |
Euclidean Capital LLC | 746,674 | $9,572,000 | 8.14% |
StepStone Group LP | 1,573,357 | $20,170,000 | 2.16% |
First Light Asset Management, LLC | 1,135,884 | $14,562,000 | 1.69% |
Lexington Partners L.P. | 110,428 | $1,416,000 | 0.73% |
Rubric Capital Management LP | 797,588 | $10,225,000 | 0.54% |
Boxer Capital, LLC | 500,000 | $6,410,000 | 0.41% |
DAFNA Capital Management LLC | 107,653 | $1,380,000 | 0.38% |